CN104387514A - Alkali-based preparation method of polyacrylic acid - Google Patents
Alkali-based preparation method of polyacrylic acid Download PDFInfo
- Publication number
- CN104387514A CN104387514A CN201410622589.9A CN201410622589A CN104387514A CN 104387514 A CN104387514 A CN 104387514A CN 201410622589 A CN201410622589 A CN 201410622589A CN 104387514 A CN104387514 A CN 104387514A
- Authority
- CN
- China
- Prior art keywords
- acid
- alkali formula
- formula preparation
- sizing material
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003513 alkali Substances 0.000 title claims abstract description 18
- 229920002125 Sokalan® Polymers 0.000 title abstract description 6
- 239000004584 polyacrylic acid Substances 0.000 title abstract description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 27
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 11
- 238000005406 washing Methods 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims abstract description 9
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 claims abstract description 8
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 8
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 claims abstract description 8
- 238000005554 pickling Methods 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 21
- 238000004513 sizing Methods 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- 238000013019 agitation Methods 0.000 claims description 10
- 230000005540 biological transmission Effects 0.000 claims description 10
- 230000003252 repetitive effect Effects 0.000 claims description 10
- 238000005201 scrubbing Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 229940026231 erythorbate Drugs 0.000 claims description 8
- 235000010350 erythorbic acid Nutrition 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 238000013467 fragmentation Methods 0.000 claims description 5
- 238000006062 fragmentation reaction Methods 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 229920000620 organic polymer Polymers 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 239000008235 industrial water Substances 0.000 abstract 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium erythorbate Chemical compound [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 abstract 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000006306 Cor pulmonale Diseases 0.000 description 4
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 2
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 208000032274 Encephalopathy Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 208000002815 pulmonary hypertension Diseases 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000003826 Respiratory Acidosis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
Landscapes
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
The invention discloses an alkali-based preparation method of polyacrylic acid and belongs to the technical field of organic polymers. The alkali-based preparation method of polyacrylic acid comprises the following steps: preparing a sodium polyacrylate size by using acrylic acid as a raw material, industrial water as a solvent, sodium hydroxide as an alkaline agent, and trimethylolpropane triacrylate, sodium persulfate and isoascorbate as accessories, and preparing the polyacrylic acid product having the particle diameter range of 104-1000 microns by steps of acid pickling, water washing, crushing, drying, crushing and the like. The alkali-based preparation method of the polyacrylic acid has the advantages that integrated feeding is adopted and processes such as dropwise addition are avoided, and therefore, the cost is saved, and meanwhile, the equipment utilization rate is increased, and the percent conversion of the product is increased; besides, the method is simple in process and convenient to operate.
Description
Technical field
The present invention relates to a kind of preparation method of organic polymer, particularly relate to a kind of polyacrylic alkali formula preparation method.
Background technology
Polyacrylic acid, as a kind of medicine intermediate, is usually applied to the circulation system disease that this class of heart trouble is more common.
The recycle system is by the sanguimotor neurohumour organizational composition of heart, blood vessel and adjustment, circulation system disease, also referred to as cardiovascular diseases, comprises the disease of above-mentioned all histoorgans, in internal disease, belongs to common disease, wherein common with heart trouble, the labor force of patient can be affected significantly.
Chronic pulmonary heart disease is a kind of comparatively common heart disease in China, and pathomechanism is pulmonary hypertension and high blood viscosity, and due to long term hypoxia, cause Pulmonary Vascular to shrink and cause Pulmonary vascular cell to thicken, cause microcirculation disturbance, pulmonary hypertension occurs.
Complication common is clinically acid base imbalance and electrolyte disturbance, and next has the infringement of upper gastrointestinal hemorrhage, shock, Liver and kidney function and pulmonary encephalopathy etc.
1, pulmonary encephalopathy: be one of modal severe complication of cor pulmonale is also the major reason causing patients with cor pulmonale death.
2, irregular pulse: various types of irregular pulse can appear in patients with cor pulmonale, wherein modal have paroxysmal supraventricular tachycardia and artrial premature beat.
3, acid base equilibrium and electrolyte balance disorder: the pulmonary heart disease compensatory phase, various types of acid base imbalance can appear in patient, and modal have metabolic acidosis and respiratory acidosis, and also likely several situation exists simultaneously.
It is several that electrolyte disturbance common are hyperkalemia, low blood sodium, low blood chlorine and hypokalemia.
4, digestive tract hemorrhage: the patient be in a bad way often increases due to anoxic, digestive tube extravasated blood and irritability Adrenal Glucocorticoids Secretion, and occurs digestive tube stress ulcer hemorrhage.
5, suffer a shock: Patients with Chronic Cor Pulmonale often there will be septic shock, hemorrhagic shock or cardiogenic shock.
Current research often finds heart trouble along with ionogen wadding disorderly, brings a series of complication simultaneously.
Meanwhile, control the electrolyte balance in human body, there is the effect alleviating complication, also can play good effect in cardiopathic treatment simultaneously.
Summary of the invention
The object of this invention is to provide a kind of polyacrylic alkali formula preparation method, the method production technique be simple, equipment efficiency of usage is high, speed of response is fast, less energy consumption and cost is low.This product application is in medicine intermediate, sanitary product.
A kind of polyacrylic alkali formula preparation method, it is characterized in that, it comprises the following steps:
(1) in retort, drop into vinylformic acid, then add process water, be configured to acrylic acid solution;
(2) Viscoat 295 is joined in acrylic acid solution;
(3) under agitation, joined in mixing solutions by sodium hydroxide, and control temperature of reaction, temperature range is 55 ~ 100 DEG C;
(4) Sodium persulfate is added, and continuously stirring 10 ~ 60 minutes;
(5) under agitation condition, add erythorbate, and control temperature is not higher than 70 DEG C;
(6) blend glue stuff is put into stirrer, add diluted acid agitator treating 30min, discharge diluted acid, repetitive scrubbing 2 ~ 4 times, add deionized water and stirring washing 30min in the sizing material after pickling, repetitive scrubbing 2 ~ 4 times;
(7) sizing material after washing is put on transmission arid zones, deliver to cutting machine and extruding nodulizer, be broken into tiny piece;
(8) sizing material after fragmentation is placed fluidised bed drying region dry, drying temperature is 80 ~ 200 DEG C;
(9) dried sizing material is placed in pulverizer, and then encapsulate, powder particle diameter scope is 104 ~ 1000 microns.
Further, the temperature in described step (3) is set to 90 DEG C.
Further, the temperature of reaction of described step (5) is set to 60 DEG C
Further, in described step (7), the transmission efficiency of travelling belt is 40Hz.
Further, described vinylformic acid: process water: Viscoat 295: sodium hydroxide: Sodium persulfate: the ratio of erythorbate is 692:1294:3:277:1:0.2.
Further, described erythorbate is SODIUM ISOVITAMIN C.
Further, the diluted acid in described step (6) refers to hydrochloric acid or the phosphoric acid of dilution.
Compared with prior art, the present invention has following beneficial effect:
(1) preparation method provided by the invention adopts vinylformic acid to be starting material, and water is solvent, and sodium hydroxide is alkaline agent, and material source is extensive, and observable index is lower.
(2) adopt in reaction process and integrally feed intake, without the need to adopting the techniques such as droppings, operation is relatively simple, and required equipment is eased, economic saving.
(3) method of the present invention's employing is effective fast, and substantially reduce the reaction times, plant factor substantially increases.
(4) product cut size of the inventive method is distributed as 104 ~ 1000 microns, and steady quality is reliable, and transformation efficiency is high.
Embodiment
Below in conjunction with embodiment, the present invention is described further:
Embodiment 1
A kind of polyacrylic alkali formula preparation method, it is characterized in that, it comprises the following steps:
(1) in retort, drop into 623.22kg vinylformic acid, then add 1163.76kg process water, be configured to acrylic acid solution;
(2) 2.7401kg Viscoat 295 is joined in acrylic acid solution;
(3) under agitation, joined in mixing solutions by 249.38kg sodium hydroxide, and control temperature of reaction, temperature range is 55 DEG C;
(4) 0.936kg Sodium persulfate is added, and continuously stirring 10 minutes;
(5) under agitation condition, add 0.1872kg erythorbate, and control temperature is 60 DEG C;
(6) blend glue stuff is put into stirrer, add the hydrochloric acid agitator treating 30min of dilution, discharge the hydrochloric acid of dilution, repetitive scrubbing 3 times, add deionized water and stirring washing 30min in the sizing material after pickling, repetitive scrubbing 3 times;
(7) put by the sizing material after washing on transmission arid zones, deliver to cutting machine and extruding nodulizer, be broken into tiny piece, the transmission efficiency of travelling belt is 40Hz;
(8) sizing material after fragmentation is placed fluidised bed drying region dry, drying temperature is 80 DEG C;
(9) dried sizing material is placed in pulverizer, and then encapsulate, powder particle diameter scope is 600 ~ 900 microns.
The polyacrylic particle diameter of gained is 700 microns, be 956% at the distributive law of 104-1000 micron, moisture content is 4.5%, residual monomer content is 37ppm, salt loading degree is 53g/g, and heavy metal content is less than 20ppm, and total soluble polymer content is 0.7%, lower than 1% of regulation, sodium content is less than 0.1%.
Embodiment 2
A kind of polyacrylic alkali formula preparation method, it is characterized in that, it comprises the following steps:
(1) in retort, drop into 623.22kg vinylformic acid, then add 1163.76kg process water, be configured to acrylic acid solution;
(2) 2.7401kg Viscoat 295 is joined in acrylic acid solution;
(3) under agitation, joined in mixing solutions by 249.38kg sodium hydroxide, and control temperature of reaction, temperature range is 100 DEG C;
(4) 0.936kg Sodium persulfate is added, and continuously stirring 60 minutes;
(5) under agitation condition, add 0.1872kg erythorbate, and control temperature is 70 DEG C;
(6) blend glue stuff is put into stirrer, add the phosphoric acid agitator treating 30min of dilution, discharge the phosphoric acid of dilution, repetitive scrubbing 3 times, add deionized water and stirring washing 30min in the sizing material after pickling, repetitive scrubbing 3 times;
(7) put by the sizing material after washing on transmission arid zones, deliver to cutting machine and extruding nodulizer, be broken into tiny piece, the transmission efficiency of travelling belt is 40Hz;
(8) sizing material after fragmentation is placed fluidised bed drying region dry, drying temperature is 200 DEG C;
(9) dried sizing material is placed in pulverizer, and then encapsulate, powder particle diameter scope is 300 ~ 800 microns.
The polyacrylic particle diameter of gained is 500 microns, be 94% at the distributive law of 104-1000 micron, moisture content is 4.7%, residual monomer content is 44ppm, salt loading degree is 43g/g, and heavy metal content is less than 20ppm, and total soluble polymer content is 0.5%, lower than 1% of regulation, sodium content is less than 0.1%.
Embodiment 3
A kind of polyacrylic alkali formula preparation method, it is characterized in that, it comprises the following steps:
(1) in retort, drop into 1246kg vinylformic acid, then add 2328kg process water, be configured to acrylic acid solution;
(2) 5.48kg Viscoat 295 is joined in acrylic acid solution;
(3) under agitation, joined in mixing solutions by 499kg sodium hydroxide, and control temperature of reaction, temperature range is 90 DEG C;
(4) 1.87kg Sodium persulfate is added, and continuously stirring 40min;
(5) under agitation condition, add 0.37kg erythorbate, and control temperature is 50 DEG C;
(6) blend glue stuff is put into stirrer, add the phosphoric acid agitator treating 30min of dilution, discharge the phosphoric acid of dilution, repetitive scrubbing 4 times, add deionized water and stirring washing 30min in the sizing material after pickling, repetitive scrubbing 4 times;
(7) put by the sizing material after washing on transmission arid zones, deliver to cutting machine and extruding nodulizer, be broken into tiny piece, the transmission efficiency of travelling belt is 40Hz;
(8) sizing material after fragmentation is placed fluidised bed drying region dry, drying temperature is 130 DEG C;
(9) dried sizing material is placed in pulverizer, and then encapsulate, powder particle diameter scope is 300 ~ 1000 microns.
The polyacrylic particle diameter of gained is 700 microns, be 93% at the distributive law of 104-1000 micron, moisture content is 4.2%, residual monomer content is 33ppm, salt loading degree is 45g/g, and heavy metal content is less than 20ppm, and total soluble polymer content is 0.8%, lower than 1% of regulation, sodium content is less than 0.1%.
The foregoing is only some embodiments of the present invention, do not limit the present invention, the technical scheme that the mode that all employings are equal to replacement or equivalent transformation obtains, all drop in protection scope of the present invention.
Claims (7)
1. a polyacrylic alkali formula preparation method, it is characterized in that, it comprises the following steps:
(1) in retort, drop into vinylformic acid, then add process water, be configured to acrylic acid solution;
(2) Viscoat 295 is joined in acrylic acid solution;
(3) under agitation, joined in mixing solutions by sodium hydroxide, and control temperature of reaction, temperature range is 55 ~ 100 DEG C;
(4) Sodium persulfate is added, and continuously stirring 10 ~ 60 minutes;
(5) under agitation condition, add erythorbate, and control temperature is not higher than 70 DEG C;
(6) blend glue stuff is put into stirrer, add diluted acid agitator treating 30min, discharge diluted acid, repetitive scrubbing 2 ~ 4 times, add deionized water and stirring washing 30min in the sizing material after pickling, repetitive scrubbing 2 ~ 4 times;
(7) sizing material after washing is put on transmission arid zones, deliver to cutting machine and extruding nodulizer, be broken into tiny piece;
(8) sizing material after fragmentation is placed fluidised bed drying region dry, drying temperature is 80 ~ 200 DEG C;
(9) dried sizing material is placed in pulverizer, and then encapsulate, powder particle diameter scope is 104 ~ 1000 microns.
2. one according to claim 1 polyacrylic alkali formula preparation method, is characterized in that: the temperature in described step (3) is set to 90 DEG C.
3. one according to claim 1 polyacrylic alkali formula preparation method, is characterized in that: the temperature of reaction of described step (5) is set to 60 DEG C.
4. one according to claim 1 polyacrylic alkali formula preparation method, is characterized in that: in described step (7), the transmission efficiency of travelling belt is 40Hz.
5. one according to claim 1 polyacrylic alkali formula preparation method, is characterized in that: described vinylformic acid: process water: Viscoat 295: sodium hydroxide: Sodium persulfate: the ratio of saccharosonic acid is 692:1294:3:277:1:0.2.
6. one according to claim 1 polyacrylic alkali formula preparation method, is characterized in that: described erythorbate is SODIUM ISOVITAMIN C.
7. one according to claim 1 polyacrylic alkali formula preparation method, is characterized in that: the diluted acid in described step (6) is hydrochloric acid or the phosphoric acid of dilution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410622589.9A CN104387514A (en) | 2014-11-08 | 2014-11-08 | Alkali-based preparation method of polyacrylic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410622589.9A CN104387514A (en) | 2014-11-08 | 2014-11-08 | Alkali-based preparation method of polyacrylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104387514A true CN104387514A (en) | 2015-03-04 |
Family
ID=52605485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410622589.9A Pending CN104387514A (en) | 2014-11-08 | 2014-11-08 | Alkali-based preparation method of polyacrylic acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104387514A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872890A (en) * | 2006-06-30 | 2006-12-06 | 上海华谊丙烯酸有限公司 | Method for preparing high absorptive resin in acrylic acid type |
| CN101094696A (en) * | 2004-12-30 | 2007-12-26 | 巴斯福股份公司 | Superabsorbent polymer particles with reduced amount of fine-sized particles and method for their production |
| CN101100493A (en) * | 2007-06-29 | 2008-01-09 | 上海华谊丙烯酸有限公司 | Method for fast preparing high water absorption resin |
| WO2008037672A1 (en) * | 2006-09-25 | 2008-04-03 | Basf Se | Method for the classification of water absorbent polymer particles |
| CN104114591A (en) * | 2012-02-15 | 2014-10-22 | 巴斯夫欧洲公司 | Water-absorbing polymer particles having a high swelling rate and high permeability |
-
2014
- 2014-11-08 CN CN201410622589.9A patent/CN104387514A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101094696A (en) * | 2004-12-30 | 2007-12-26 | 巴斯福股份公司 | Superabsorbent polymer particles with reduced amount of fine-sized particles and method for their production |
| CN1872890A (en) * | 2006-06-30 | 2006-12-06 | 上海华谊丙烯酸有限公司 | Method for preparing high absorptive resin in acrylic acid type |
| WO2008037672A1 (en) * | 2006-09-25 | 2008-04-03 | Basf Se | Method for the classification of water absorbent polymer particles |
| CN101100493A (en) * | 2007-06-29 | 2008-01-09 | 上海华谊丙烯酸有限公司 | Method for fast preparing high water absorption resin |
| CN104114591A (en) * | 2012-02-15 | 2014-10-22 | 巴斯夫欧洲公司 | Water-absorbing polymer particles having a high swelling rate and high permeability |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101880354B (en) | High molecular emulsion polymer and preparation method thereof | |
| CN102813637B (en) | Kallidinogenase enteric coated tablet and preparation method thereof | |
| CN107663241A (en) | A kind of crosslinked starch of high resistant starch content and preparation method thereof | |
| CN108046648A (en) | A kind of preparation method of foam concrete foamer | |
| CN102212143A (en) | Pollution-free preparation method for oxidized phosphated double-modified starch | |
| CN104045840A (en) | Method for low-temperature dissolution of graft-modified cellulose | |
| CN105218731A (en) | A kind of shock resistance type chloroethylene copolymer resin and preparation method thereof | |
| US9376514B2 (en) | Vinyl chloride latex with low energy consumption and method for preparing the same | |
| CN104387514A (en) | Alkali-based preparation method of polyacrylic acid | |
| CN102898580A (en) | Method for preparing polyacrylamide | |
| CN102533042B (en) | Preparation method of acrylic organic bentonite polyvinyl acetate emulsion paint | |
| CN101311237A (en) | Fluororubber adhesion promoter and method for preparing same | |
| CN102276733B (en) | Method for preparing ethyl cellulose with high degree of substitution | |
| CN105273111B (en) | A kind of method of stripper plant fouling in reduction Production of PVC | |
| CN103833541A (en) | Novel synthesis method of 2-methyl-1,4-naphthoquinone | |
| CN101823955B (en) | Method for extracting ferulic acid from maize peels | |
| CN102422848B (en) | Preparation method of immobilized glucose oxidase with muscle strengthening function in production process of bread | |
| CN102911303B (en) | A kind of pvc resin paste grade for the preparation of medical gloves and production method thereof | |
| CN103087266A (en) | Modified superabsorbent sweet potato starch and preparation method thereof | |
| CN106905203B (en) | A kind of synthetic method to methylsulfonyl Phenserine ethyl ester | |
| CN103146163B (en) | Preparation method of polylactic acid nucleating agent | |
| CN106634732A (en) | Process for producing paper pipe glue from isooctyl ester wastewater | |
| CN105218357A (en) | A kind of preparation method of zinc citrate | |
| CN105237388B (en) | A kind of high purity methacrylic acid monomer salt and preparation method | |
| CN111303354B (en) | A "Gradient Initiation" Method Applicable to the Preparation of Composite Superabsorbent Resins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150304 |